I recommend against relying on any data I provide in today’s post. I hope the data are at least somewhat accurate. But they are not nearly as accurate as they should be, or as they could be, if FDA just released a key bit of information they have been promising to share for years.
One of the ways data scientists can provide insights is by grafting together data from different sources that paint a picture not seen elsewhere. What I want to do is join the clinical trial data at www.clinicaltrials.gov with the data maintained by FDA of approved drugs, called drugs@FDA. But I can’t, at least not with much accuracy.
Continue Reading Unpacking Averages: Connecting Published Clinical Trials with FDA Drug Approvals